The Proposed RuleWaivers
The requirement would be waived for some or all pediatric age groups, if:
(1) the product did not represent a meaningful therapeutic benefit for pediatric patients and was unlikely to be used in a substantial number of pediatric patients;
(2) studies impossible or highly impractical, e.g., population too small;